Acute Lymphoblastic Leukemia
📧 Sign up to get email alerts when something new happens for Acute Lymphoblastic Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-02-25Clinical Trial Update: PTCy and ATG for MSD and MUD Transplants [Phase 1, Phase 2]
Ongoing Phase 1/2 clinical trial evaluating post-transplant cyclophosphamide and anti-thymocyte globulin for matched sibling and matched unr…
-
CLINICAL_TRIALS research · 2025-02-18Clinical Trial Update: A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of MSD-HSCT Using a TBI or TMLI Conditioning Regimen for Adult ALL [Phase 2]
Phase 2, open-label, randomized multicenter trial evaluating matched sibling donor hematopoietic stem cell transplantation using total body …
-
CLINICAL_TRIALS research · 2025-02-18Clinical Trial Update: A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of Haplo-HSCT Using a TBI or TMLI Conditioning Regimen for Pediatric ALL [Phase 2]
This Phase 2 prospective, open-label, randomized multicenter study evaluates haploidentical hematopoietic stem cell transplantation with eit…
-
CLINICAL_TRIALS research · 2025-02-18Clinical Trial Update: Low GI Diet in Children and Adolescents With ALL [NA]
A Columbia University-sponsored clinical trial update describes an active-not-recruiting study evaluating a low-GI diet in children and adol…
-
CLINICAL_TRIALS trial_result · 2025-02-18Clinical Trial Update: The Effect of Non-pharmacological Methods on Pain [NA]
A completed clinical trial evaluating non-pharmacological methods to alleviate pain in infants, including those with infant acute lymphoblas…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-02-18Clinical Trial Update: A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of Haplo-HSCT Using a TBI or TMLI Conditioning Regimen for Adult ALL [Phase 2]
A Phase 2 multicenter, prospective, open-label randomized study evaluating haploidentical hematopoietic stem cell transplantation with TBI o…
-
CLINICAL_TRIALS trial_result · 2025-02-17Clinical Trial Update: Combination Chemotherapy and Dasatinib in Treating Participants With Philadelphia Positive or BCR-ABL Positive Acute Lymphoblastic Leukemia. [Phase 2]
Phase 2 trial evaluating the combination of chemotherapy with dasatinib in Philadelphia chromosome–positive or BCR-ABL–positive acute lympho…
-
CLINICAL_TRIALS trial_result · 2025-02-13Clinical Trial Update: First-in-Human (FIH) Trial of 1A46 in Subjects with Advanced CD20 And/or CD19 Positive B-cell Hematologic Malignancies [Phase 1, Phase 2]
A first-in-human study of the investigational agent 1A46 in advanced CD20/CD19-positive B-cell hematologic malignancies has been terminated;…
-
CLINICAL_TRIALS trial_result · 2025-02-07Clinical Trial Update: Behavioral Parenting Skills As A Novel Target for Improving Pediatric Medication Adherence
This document reports on a completed clinical trial exploring whether behavioral parenting skills can improve medication adherence in childr…
-
CLINICAL_TRIALS research · 2025-02-07Clinical Trial Update: Newly-diagnosed Intermediate/High Risk Pediatric B-cell ALL Protocol [Phase 2, Phase 3]
A multicenter Phase 2/3 pediatric trial protocol for newly diagnosed intermediate/high risk B-cell acute lymphoblastic leukemia is currently…
-
CLINICAL_TRIALS trial_result · 2025-02-05Clinical Trial Update: Anti-CD19 CAR T Cells in Pediatric Patients Affected by Relapsed/Refractory CD19+ ALL and NHL [Phase 1, Phase 2]
Phase 1/2 trial evaluating anti-CD19 CAR T cells in pediatric patients with relapsed/refractory CD19+ acute lymphoblastic leukemia and non-H…
-
CLINICAL_TRIALS research · 2025-02-05Clinical Trial Update: Validating the Spanish "Attitudes Toward Genomics and Precision Medicine" (AGPM). [NA]
A Boston College-sponsored clinical trial is listed as ACTIVE_NOT_RECRUITING to validate attitudes toward genomics and precision medicine in…
-
CLINICAL_TRIALS trial_result · 2025-02-04Clinical Trial Update: The Ratio of Femoral Vein Diameter to Femoral Artery Diameter to Predict Fluid Responsiveness in Children
A completed clinical trial at Tanta University investigates whether the ratio of femoral vein diameter to femoral artery diameter can predic…
-
CLINICAL_TRIALS withdrawal · 2025-02-03Clinical Trial Update: Expanded Access Program of Venetoclax and Navitoclax for Pediatric Patients with Relapsed or Refractory ALL or LL
Expanded access program for venetoclax and navitoclax in pediatric relapsed/refractory acute lymphoblastic leukemia or lymphoblastic lymphom…
-
CLINICAL_TRIALS research · 2025-01-31Clinical Trial Update: Virtual Remote Physiological Monitoring Program of Children With Heart Disease [NA]
This clinical trial update describes the completion of a virtual remote physiological monitoring program for children with heart disease at …
-
CLINICAL_TRIALS research · 2025-01-31Clinical Trial Update: Bright Ideas - CIN Feasibility Study [NA]
A CIN feasibility study for Acute lymphoblastic leukemia is currently recruiting.
-
CLINICAL_TRIALS research · 2025-01-31Clinical Trial Update: Effects of Core Stabilization Exercises in Children with Acute Lymphoblastic Leukemia [NA]
This clinical trial is evaluating the effects of core stabilization exercises in children with acute lymphoblastic leukemia and is currently…
-
CLINICAL_TRIALS research · 2025-01-29Clinical Trial Update: Digital Health Promotion for Children With Congenital Heart Disease and Their Guardians [NA]
This update describes an ongoing clinical trial testing a digital health promotion program for children with congenital heart disease and th…
-
CLINICAL_TRIALS trial_result · 2025-01-27Clinical Trial Update: Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia [Phase 1]
This clinical trial update summarizes Phase I results for GNKG168 in relapsed acute lymphoblastic leukemia and relapsed acute myeloid leukem…
-
CLINICAL_TRIALS trial_result · 2025-01-27Clinical Trial Update: Safety and Clinical Activity of KT-253 in Adult Patients with High Grade Myeloid Malignancies, Acute Lymphocytic Leukemia, Lymphoma, Solid Tumors [Phase 1]
Phase 1 clinical trial evaluating safety and preliminary activity of KT-253 in adults with high-grade myeloid malignancies, acute lymphoblas…
-
CLINICAL_TRIALS trial_result · 2025-01-24Clinical Trial Update: A Study of CTA30X Cell Injection in Patients With Relapsed or Refractory CD19-positive B-line Hematological Malignancies [EARLY_Phase 1]
A Phase 1 study evaluating CTA30X cell injection in relapsed or refractory CD19-positive B-line hematological malignancies has completed.
-
CLINICAL_TRIALS trial_result · 2025-01-22Clinical Trial Update: Sequential Chemotherapy and Blinatumomab to Improve MRD Response and Survival in Acute Lymphoblastic Leukemia [Phase 2]
Phase 2 trial evaluating sequential chemotherapy followed by blinatumomab in Philadelphia chromosome-negative B-cell precursor acute lymphob…
-
CLINICAL_TRIALS research · 2025-01-20Clinical Trial Update: A Novel CAR-T Combined Expression of IL-15 in the Treatment of Malignant Hematological Tumors [NA]
A Clinical Trial Update describes a novel CAR-T therapy expressing IL-15 for malignant hematological tumors, with recruitment ongoing and no…
-
CLINICAL_TRIALS trial_result · 2025-01-20Clinical Trial Update: Physical Activity in Acute Lymphoblastic Leukemia (ALL) [NA]
A completed clinical trial from University of California, Irvine examining physical activity in patients with acute lymphoblastic leukemia.
-
CLINICAL_TRIALS research · 2025-01-15Clinical Trial Update: Inaticabtagene Autoleucel (Inati-cel; CNCT19) Treatment for Newly Diagnosed B-cell ALL Patients in CR1 [Phase 2]
Phase 2 study of Inati-cel (Inaticabtagene Autoleucel) for newly diagnosed B-cell acute lymphoblastic leukemia in CR1 is not yet recruiting.